Sectra (OMX:SECTB) announced that it sold its MicroDose mammography sector to Royal Philips Healthcare (NYSE:PHG) this week.Philips paid $82 million in cash up front, and the agreement includes room for $18 million more pending specially agreed terms and conditions.About 110 Sectra employees are expected to transfer with the business.var page_count = “off”; [...]
[Read more of this report]Masimo Corp. (NDSQ:MASI) announced today that it reached a long-term non-exclusive agreement to integrate its rainbow SET technology into Philips Healthcare’s products.The terms of the agreement were not disclosed.This could be a positive step for both companies, which have had some tough news recently.Philips recalled its infant breathing lines last month [...]
[Read more of this report]Philips Healthcare‘s computed tomography and nuclear medicine headquarters in suburban Cleveland has received a warning letter from the U.S. Food and Drug Administration, primarily over quality control and record-keeping issues.The FDA listed 15 specific violations uncovered during inspections of Philips’s imaging center in Highland Heights, Ohio last year. For example, the company failed to report [...]
[Read more of this report]Most people in Ohio’s biomedical industry would’ve considered 2010 a good year if just one key thing happened — voters renewed the state’s $1.35 billion, 10-year Third Frontier program, which is designed to energize Ohio’s economy by investing in cutting-edge technology. It happened and heads up MedCity News’ list of the biggest highlights of the year for Ohio’s biomedical industry.
[Read more of this report]As the history of social legislation suggests — and as this week’s federal court ruling on the so-called individual mandate makes clear, the effects of healthcare reform on our politics may not be settled until a lot of President Obama’s aides are collecting Medicare checks, according to the New York Times.
[Read more of this report]The Food & Drug Administration today announced a program for improving the safety and efficacy of automated external defibrillators.The federal watchdog agency said it’s received 28,000 reports of AED failures in the last five years, yet 300,000 Americans could benefit from treatment from the devices every year.AEDs are designed to treat cardiac [...]
[Read more of this report]Sales for Philips Healthcare during the three months ended Sept. 30 were about $321 million higher than the $2.35 billion in global sales reported for Q3 2009.The Royal Philips Electronics (NYSE:PHG) division recorded $2.67 billion in third-quarter revenues, a 13.6 percent increase.Earnings before interest, taxes and amortization for the North Andover, Massachusetts-based [...]
[Read more of this report]This fall, BioOhio will hold its Annual Conference in three regions on three different dates. ’Innovation Road Show’ will visit northeast Ohio on September 28, central Ohio on October 28, and southwest Ohio on November 17. At all three sites, the emphasis will be on biomedical innovation ’ defining it, discussing it, debating it, and understanding how essential it is from R&D through commercialization to market. Ample networking time will be available for Ohio’s bioscience innovators to share ideas and initiate collaborations.
[Read more of this report]The Dutch parent of Philips Healthcare has joined a $250 million venture fund that will invest in innovative early and growth-stage healthcare technology companies in Europe and the United States. Royal Philips Electronics (NYSE: PHG) has made an undisclosed “minority share” investment in Gilde Healthcare III, which will invest in home healthcare solutions, sleep improvement techniques, image-guided interventions and therapies, and clinical decision support.
[Read more of this report]Ohio Third Frontier commissioners made a slew of biomedical grants under two programs today.Recommended for more than $4.9 million under the Ohio Third Frontier Biomedical Program:– CardioX Corp., Dublin, in collaboration with Nottingham-Spirk Design Associates in Cleveland and QTest Labs in Columbus, was awarded $986,373 to finalize designs and clinical protocols for a new method [...]
[Read more of this report]